Literature DB >> 1675561

Virus-induced amyloidosis in scrapie involves a change in covalent linkages in the preamyloid.

H Diringer1, H Blode, U Oberdieck.   

Abstract

Preparations of the preamyloid and the amyloid protein from normal and scrapie hamster brains show different solubilization behaviours towards Triton X-114 extraction. The normal isoform is completely extractable from microsomal membranes by the detergent, whereas the pathological one is not. Both forms can be isolated using preparative SDS electrophoresis as the final step in order to remove all non-covalently associated materials. After removal of the SDS these purified proteins retain their solubility differences against Triton X-114. This demonstrates that at least one distinct modification of the preamyloid protein--which has to be covalent in nature--must have occurred to account for the strong aggregation tendency of the pathological isoform.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675561     DOI: 10.1007/bf01311308

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  Scrapie prion protein contains a phosphatidylinositol glycolipid.

Authors:  N Stahl; D R Borchelt; K Hsiao; S B Prusiner
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

Review 2.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

3.  Abnormal fibrils from scrapie-infected brain.

Authors:  P A Merz; R A Somerville; H M Wisniewski; K Iqbal
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

4.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

5.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

6.  Characterization of antisera against scrapie-associated fibrils (SAF) from affected hamster and cross-reactivity with SAF from scrapie-affected mice and from patients with Creutzfeldt-Jakob disease.

Authors:  L Bode; M Pocchiari; H Gelderblom; H Diringer
Journal:  J Gen Virol       Date:  1985-11       Impact factor: 3.891

7.  Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally.

Authors:  M Czub; H R Braig; H Diringer
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

  7 in total
  5 in total

1.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 2.  Transmissible spongiform encephalopathies (TSE) virus-induced amyloidoses of the central nervous system (CNS).

Authors:  H Diringer
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

Review 3.  The transmissible amyloidoses: genetical control of spontaneous generation of infectious amyloid proteins by nucleation of configurational change in host precursors: kuru-CJD-GSS-scrapie-BSE.

Authors:  D C Gajdusek
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

Review 4.  Prions, beta-sheets and transmissible dementias: is there still something missing?

Authors:  P P Liberski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Characterisation of antisera raised against species-specific peptide sequences from scrapie-associated fibril protein and their application for post-mortem immunodiagnosis of spongiform encephalopathies.

Authors:  U Oberdieck; Y G Xi; M Pocchiari; H Diringer
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.